Science's Retinal Implant (Prima) Science's BCI treatment involves a tiny silicon chip implanted under the retina. This chip acts as a retinal stimulator, bypassing damaged rods and cones. Patients wear glasses with a camera and laser projector that sends images to the implant. The implant absorbs laser light and excites cells, restoring some vision for those who have lost sight due to retinal degeneration. A large clinical trial in Europe showed significant positive effects, and approval is being sought. The Nature of Brain-Computer Interfaces (BCIs) BCIs are not a single product but a category of technologies for different applications. They can be used to restore lost functions (sight, hearing, movement) or for structural neural engineering (enhancing cognition, treating mental health issues). BCIs are moving beyond restoring functionality to potentially augmenting human capabilities. Different modalities, like ultrasound and implantable chips, will serve different purposes. Neuroplasticity and Learning While there are critical periods in early development, the brain remains significantly plastic throughout adulthood. The brain can learn to control neural activity through feedback, as seen in cortical motor decoders. The brain adapts to new inputs and can learn to interpret them, even if the initial wiring was for different functions. The brain's plasticity is often stable due to its adaptation to reality, forming "basins" in an "energy surface." The Qualia of Artificial Vision and Beyond The qualia of Science's Prima implant is described as normal, albeit black and white with a limited field of view. Blind patients' brains, deprived of visual input, may generate internal perceptions that need to be dissociated from real input during rehab. The potential qualia of ultra-high bandwidth bio-hybrid neural interfaces are difficult to imagine, with conjoined twins offering a glimpse into shared conscious experience. Future of BCIs and Healthcare Within 10 years, BCIs may approach native visual acuity, including color and a wider field of view. BCIs are seen as a neural engineering approach to medicine, potentially more effective than drug discovery for certain conditions. The goal extends beyond restoring function to fundamentally reframing medicine and human capabilities. BCIs are poised to impact vision, hearing, balance, motor control, and potentially longevity. Technical Aspects and "The API of the Brain" The brain's input/output is through cranial and spinal nerves, which can be considered its "API." Understanding this API allows for new ways to interact with the brain's information processing. Progress in AI has led to a unification with neuroscience, with AI models exhibiting representations similar to those in the brain. BCI development is limited by the ability to record and stimulate neural signals, with the retina's layered structure being a key area of study. Science stimulates bipolar cells in the retina, which is a critical processing step, allowing for image formation in the mind's eye. Science's Bio-hybrid Approach Science is developing bio-hybrid neural interfaces by culturing engineered neurons onto implants. These engineered neurons are hidden from the immune system, avoiding the need for immunosuppressants. This approach aims to create new biological connections without genetically modifying the patient's brain. The concept is compared to growing a new cranial nerve or the "ponytails" in the movie Avatar, forming a new biological interface. Neural Representations and Latent Spaces The brain contains "representations" of concepts, like hand activity or objects, which can be mapped. Deeper brain areas exhibit abstract representations, similar to latent spaces found in AI models. This convergence of AI and neuroscience suggests that AI models are on the right track in understanding brain function. The "Smartphone Dividend" and Motor Decoding The development of efficient, small, and low-power electronics, driven by the smartphone industry, has been crucial for implantable BCIs. Closing the skin over implants is important to prevent infection, requiring highly efficient electronics that don't generate excessive heat. Motor decoding, enabling cursor or keyboard control, has been a foundational BCI application since the late '90s. The Vessel Program and Profusion Technology Science is also working on profusion technology for life support, inspired by cases like a teenager kept alive on ECMO. The goal is to improve profusion systems to be more accessible and allow for higher quality of life, moving beyond "bridge to nowhere" scenarios. This involves refining the technology to make it portable and integrate seamlessly with the body, addressing issues like skin healing around implants. Early Days and Motivation Max Hodak's early interest in BCIs was fueled by science fiction, particularly "The Matrix," and a fascination with the brain as a computer. He co-founded Neuralink with the motivation to "upgrade humanity" in the face of advancing AI, preventing humans from being left behind. The initial Neuralink team was formed from a small community of researchers. Hodak emphasizes the importance of high agency and persistence in pursuing a clear vision, but also the value of learning from experienced individuals and companies. The Future Horizon and Exceptional Change Hodak believes we are in an "era of takeoff" for BCIs, marking a significant new phase for humanity. He predicts that the first people to live to a thousand may already be alive, driven by technological advancements. The next 15 years are expected to bring transformative changes comparable to the early impact of the Industrial Revolution. BCIs and AI are seen as parallel yet distinct forces that will reshape intelligence availability, human agency, and the human condition.